Skip to main navigation

Top Navigation

Publications
Newsroom
Investors
Blog
Careers
Contact Us

mRNA Technology
Modalities
Pipeline
- Clinical Trials
- Therapeutic Areas
Ecosystem
- Strategic Collaborators
- New Venture Labs
About Us

Investors

IR Navigation

Overview
Stock Information
Corporate Governance
SEC Filings
Events & Presentations
Press Releases
Shareholder Resources

Investor Relations

Day High

Day Low

Volume

4:12 PM EDT
September 22, 2019

Copyright West LLC.
Minimum 15 minutes Delayed.

Press Releases

September 12, 2019

Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)

September 12, 2019

Moderna Announces Positive Interim Results from Phase 1 Cytomegalovirus (CMV) Vaccine (mRNA-1647) Study and Progress Toward Phase 2 and Pivotal Trials

September 4, 2019

Moderna Appoints Tracey Franklin as Chief Human Resources Officer

View All Press Releases

Events

No events are currently scheduled.

View All Events

Presentations

Moderna 2019 R&D Day Presentation

Corporate Presentation

Pipeline Program Detail

IR Contact

IR@modernatx.com

Email Alerts

Click Here to have company news delivered to your inbox

mRNA Technology
Modalities
Pipeline
Ecosystem
About Us

Publications
Newsroom
Investors
Blog
Careers
Contact Us

Facebook
Twitter
Youtube
LinkedIn

Footer Menu - Bottom

© 2019 Moderna, Inc.
Privacy Policy
Join our Mailing List
Terms of Use

×

You are now leaving investors.modernatx.com, a website provided by Moderna. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. The content displayed on external websites is not controlled by Moderna, and Moderna assumes no responsibility for the information or statements on such external websites.